Fig. 7

Model for IAV NS1-mediated immune evasion through targeting TRAF3 to impair the RIG-I, TLR3, and TLR7 pathways to type I IFN production. RIG-I, TLR3, and TLR7 are involved in detecting IAV RNA to trigger type I IFN-mediated antiviral immunity. IAV NS1 interacted with TRAF3 through its TRAF3-binding motif (TIM) in the C-terminal effector domain. This interaction blocked TRAF3 ubiquitination and activation, which is required for RIG-I, TLR3, and TLR7 pathways to type I IFN production